Stefan Bracht

Head of Drug Delivery Innovation @Bayer

Berlin, DE
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2022 — Present

Head of Drug Delivery Innovation @Bayer

View department →

Berlin, DE

Leading the DDI team in Bayer means to best enable the expansion of the druggable target space which our Research units are aiming at in the wide range of New Therapeutic Modalities from chemical APIs up to CGT. Our focus is on overcoming the oral barrier with BCS class compounds, cutting edge non viral vectors e.g. LNP and certainly on enabling very poorly soluble componds on the oral route. Additional focus areas are s.c. depots for e.g. peptides, organ targeting to brain, heart, or kidney and precision cancer and tumor targeting.

EDUCATION

1987 — 1990

Technische Universität Braunschweig

Pharmacist, Pharmaceutics

SKILLS

Drug DeliveryPharmaceuticsFormulationPharmaceutical IndustryRadiopharmaDrug DevelopmentBiopharmaceuticalsBiologicsTechnology TransferLife SciencesSourcingGmpProtein ChemistryR&DValidationCROMedical Devices

ABOUT STEFAN BRACHT

Long-term expert in drug delivery with in-depth exerience in polymer based drug delivery and formulation / drug delivery of protein drugs.Management experience from cross cultural teams and very broad range of technical experts.Deeply experienced in all business models and alliances of drug product development: working as external CRO for customers, execution of purely internal development, and developing products with external CROs/CMO.Expertise covers broad range of pharmaceutical technologies and processes for small and large molecules including radiopharmaceuticals.Personal interest is in solid dispersions, ocular drug delivery,(depot) particle design, protein formulation

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Stefan Bracht — Head of Drug Delivery Innovation at Bayer in Berlin, DE | Unifers